Literature DB >> 24370613

Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency.

Antonia Sophocleous1, Andrew H Sims, Aymen I Idris, Stuart H Ralston.   

Abstract

Previous studies have shown that the skeletal consequences of cannabinoid receptor deficiency differ in different strains of mice. In order to explore the mechanisms responsible, we analysed global gene expression in bone from wild-type CD1 mice and littermates with targeted inactivation of the type 2 cannabinoid receptor (Cnr2 (-/-)) and compared the results with those obtained from a similar analysis of wild-type and Cnr2 (-/-) C57BL/6 mice. Trabecular bone volume was increased in Cnr2 (-/-) CD1 mice compared with wild-type littermates but decreased in Cnr2 (-/-) C57BL/6 mice. Microarray analysis identified 354 genes in which substantial differences in gene expression (>1.5-fold) were observed that were specifically affected by Cnr2 deficiency. Bioinformatic analysis of data from wild-type mice of each strain revealed Cnr2-dependent differences in expression of genes clustering within the gene ontology (GO) terms immune response (p < 0.0001), positive regulation of response to stimulus (p < 0.0001), nucleotide binding (p = 0.002), and ribonucleotide binding (p = 0.003). Bioinformatic analysis of data from Cnr2 (-/-) mice of each strain revealed associations between GO terms corresponding to the extracellular region (p = 0.002), the cell surface (p = 0.02), antigen binding (p = 0.03), external side of plasma membrane (p = 0.04), and regulation of the force of heart contraction (p = 0.04). We conclude that Cnr2 deficiency affects expression of a large number of genes in different strains of mice, and that these differences are likely to be responsible in part for the differences in skeletal phenotype that we and others have observed in mice with defective cannabinoid receptor signalling in different genetic backgrounds.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370613     DOI: 10.1007/s00223-013-9823-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  5 in total

1.  Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis.

Authors:  Diane S Abou; David Ulmert; Michele Doucet; Robert F Hobbs; Ryan C Riddle; Daniel L J Thorek
Journal:  J Natl Cancer Inst       Date:  2015-12-18       Impact factor: 13.506

2.  Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.

Authors:  Antonia Sophocleous; Silvia Marino; Dilruba Kabir; Stuart H Ralston; Aymen I Idris
Journal:  Aging Cell       Date:  2017-07-28       Impact factor: 9.304

3.  Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.

Authors:  Silvia Marino; Daniëlle de Ridder; Ryan T Bishop; Nathalie Renema; Marco Ponzetti; Antonia Sophocleous; Mattia Capulli; Abdullah Aljeffery; Giovana Carrasco; Marianela Dalghi Gens; Asim Khogeer; Stuart H Ralston; Jürg Gertsch; Francois Lamoureux; Dominique Heymann; Nadia Rucci; Aymen I Idris
Journal:  EBioMedicine       Date:  2019-05-29       Impact factor: 8.143

Review 4.  The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.

Authors:  Federica Saponaro; Rebecca Ferrisi; Francesca Gado; Beatrice Polini; Alessandro Saba; Clementina Manera; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

5.  Impact of the Endocannabinoid System on Bone Formation and Remodeling in p62 KO Mice.

Authors:  Christina Keller; Timur Alexander Yorgan; Sebastian Rading; Thorsten Schinke; Meliha Karsak
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.